US 7879984
Human antibodies to human CD20 and method of using thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 7879984 (Human antibodies to human CD20 and method of using thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/04, A61P11/00